District Court in Texas rejected a request from compounders for a preliminary injunction, effectively upholding a May 22 deadline set by the U.S
In Quebec, where one in four adults is obese, the current cost of these new drugs (approximately $500 per month) would involve an annual expenditure of several hundred million dollars (in the United States the situation is even worse: the cost of a 72-week course of tirzepatide (15 mg/week) is approximately US$17,000, while the 68-week treatment with semaglutide (2.4 mg/week) is nearly US$23,000!)
North America is dominating the GLP-1 analogues market, supported by a high prevalence of type 2 diabetes and obesity, strong healthcare infrastructure, and rapid adoption of innovative therapies
CrossRef PPS03 triggers cancer-selective necroptosis in hepatocellular carcinoma via macropinocytosis-dependent ROS overload Kyung Hwa Choi, Juhee Park, Hyemee Yoon, Keunwan Park, Cheolgoo Hur, Seok-Mo Kim, Ki Cheong Park, Jin Hong Lim Biomaterials .2026